AST Places Next Generation of Flexible, Isolated Fill-Finish System at Ascend Alachua Facility for Advanced Adeno-Associated Viral Vector (AAV) Production
TACOMA Wash., October 1, 2024 — AST, a leading provider of flexible aseptic filling systems, has announced the placement of a next-generation GENiSYS® C fill-finish system at the Ascend Advanced Therapies (Ascend) Alachua, FL facility. Ascend is a global gene to GMP gene therapy development partner with 58,500 square feet of recently acquired GMP manufacturing space in Alachua, a rapidly growing biotech hub and birthplace of AAV gene therapy. The new fully automated and isolated filling and closing line will be installed as part of the commercial infrastructure expansion of the Ascend Alachua facility.
The GENiSYS C is a fourth-generation fill-finish system designed to meet and exceed regulations, including the latest EU Annex 1 Manufacture of Sterile Products, and can be configured to customer needs. The automated, multi-format filling and closing system can process commercial and custom nested vials, syringes, and cartridges on a compact, no-touch production line. Fully automatic bag and tub opening, filling/closing, and vial sealing with pharmaceutical-grade aluminum capping minimize operator interaction. The fully integrated system is American-built and serviced, featuring isolator barrier technology designed in collaboration with Germfree, and groundbreaking bio-decontamination technology from CURIS System to enhance process safety and product quality.
“One of our core differentiators at Ascend is the level of investment in people and enabling technologies that we continue to make,” said Mike Stella, CEO at Ascend. “After extensive evaluation, we chose the GENiSYS C fill-finish system due to the ability to configure it to our needs and the support offered from the AST project management and aftermarket teams. In addition to being able to customize our machine, the new integrated GENiSYS C offers benefits like 60-minute cycle times (including aeration), which will have a deep impact on quality and timelines.”
The GENiSYS C placed in Alachua will utilize pre-sterilized, ready-to-use containers and features robotic tub handling and a fully automated filling and closing process to minimize human intervention. Zero-waste processing includes one hundred percent in-process weight checks with no impact to the machine throughput, and end-of-batch filling to avoid product loss. A comprehensive suite of visual and sensor-based quality checks has been customized for Ascend to maximize yield and quality.
“Both AST and Ascend have a clear commitment to flexible, innovative solutions, and that’s what makes this partnership a natural fit,” commented AST President and CEO Joe Hoff. “Ascend has a record of delivering high-yield, high-quality products and AST’s isolated GENiSYS C is a proven system designed to meet the most rigorous standards of product integrity that will aid this work well into the future. We’re thrilled to support Ascend’s crucial mission of bringing more groundbreaking gene therapies into production.”
To learn more about AST’s aseptic processing solutions, email sales@ast-inc.com. To learn more about working with Ascend, email business@ascend-adv.com.
About Ascend
Ascend Advanced Therapies (Ascend) is a specialist adeno-associated virus (AAV) development partner working to bring next-generation gene therapy products to market. Carrying forward from therapeutic development, Ascend hit the ground running in operational facilities globally. With AAV roots going back to 1991, the experienced team offers unparalleled insight and collaboration when delivering products from gene to GMP. A flexible platform supports all AAV serotypes across scales with proprietary and partnered technologies and a world-class analytical toolkit enabling the team to Aim Higher in balancing yield and quality of commercially accessible life-saving therapies. Learn more at www.ascend-adv.com.
Media Contact: media@ascend-adv.com
Website: www.ascend-adv.com
LinkedIn: https://www.linkedin.com/company/ascend-advanced-therapies/
About AST
AST is a pioneering force in aseptic fill-finish processing technology, committed to pushing the boundaries of industry standards. With a rich history of innovation, AST delivers cutting-edge solutions that enable pharmaceutical manufacturers to achieve optimal efficiency and product quality.
Media Contact: Brittany Cooksey, Marketing Manager, marketing@ast-inc.com
Website: www.ast-inc.com
LinkedIn: https://www.linkedin.com/company/automated-systems-of-tacoma/
